Procopio Life Sciences CEO Connection

Procopio's Life Sciences CEO Connection program offers an unparalleled opportunity for select early-stage life science CEOs to engage in a vibrant, monthly, peer-to-peer forum. This exclusive, invite only program is limited to 20 life science CEOs in each location, fosters meaningful connections and provides participants with the support needed to address the unique challenges of leadership in the life science sector.

3 Chapters

Held monthly at Procopio's law firm offices in Irvine, Palo Alto, and San Diego, California, the CEO Connection program is thoughtfully curated by industry insiders, ensuring a sharp focus on the most pressing business issues that matter to you.

Our Mission

Our mission is to empower CEOs, helping you navigate your business from its current position to where you envision it to be. The program covers a diverse array of topics, including capital raising, IP and licensing, talent management, growth strategies, conflict resolution, and more.

Knowledge Share

Dynamic roundtable discussions allow for candid conversation around the issues impacting your business's success. Raise topics challenging your growth and success, and benefit from the collective wisdom and strategic insights of your peers.

Program Details

*Limited to a select group of 20 CEO's

*Life Science focus

*12-month program

*Program fee: $1,000

SUBMIT YOUR CEO APPLICATION

Benefits of joining this exclusive Roundtable

Participating in the Life Sciences CEO Connection program is an invaluable experience, offering you the opportunity to connect with fellow industry CEOs, learn from their expertise, and receive practical advice and guidance on overcoming your key challenges.

While the discussions tackle serious subjects, the program maintains a light and focused atmosphere. We also provide on-demand educational content from leading experts, with topics determined by the participants themselves.

Typical Participant Company Characteristics

Funding

Seed to Pre-series B / Cross-over

Pre-revenue Stage

Discovery, Preclinical, IND- Enabling

Focus

Life Sciences, Therapeutics, Medical Device, Med Tech, Health-Tech, ML/AI, Dx / Tools, CRO/ CDMO

Growth Collaborations

Partnering

Liquidity Plans

IPO, SPAC, Reverse Merge, M&A

Employees

Legal Considerations

IP strategy, Entity Formation and Planning, Financing, Transactional, Licensing

SUBMIT A CEO NOMINATION

Guiding the program are distinguished leaders in Life Sciences.

Life Sciences Venture Investor

David Crean

David is recognized as an accomplished strategic business advisor for life science companies. He is a successful business leader, known for fostering engaging and constructive conversations in the life science community.

Procopio_Johnson_Paul_Bio Photo color 1081

Procopio Partner

Paul B. Johnson

Paul is the leader of Procopio's Emerging Growth & Venture Capital practice helping entrepreneurs and their investors get companies formed, funded and sold, including negotiation of seed, early and mid-stage equity financings and buy and sell-side mergers and acquisitions. Paul has also counseled some of San Diego’s most successful companies in Securities and Exchange Commission compliance and general corporate governance.

Procopio Partner

Noel Gillespie

Noel advises start up and emerging growth clients on strategic patent portfolio development and implementation and brings extensive experience working with digital health, health information technology, and medical devices companies.

Procopio Partner

Xiaofan “Frank” Yang, PhD

Dr. Yang provides comprehensive IP strategic counseling to public and private biotechnology, pharmaceutical, digital health and medical device companies. After obtaining his B.S. in polymer chemistry and Ph.D. in organic synthesis, Dr. Yang worked as a medicinal chemist in the pharmaceutical industry for more than four years before becoming a patent practitioner in 2006.

Arrow Up Partners CEO

John Foley

John is a senior integrated marketing, strategist, and creative partner for senior-level executives at middle market companies for over 15 years. Earlier in his career, John led large-scale integrated marketing and creative initiatives for Fortune 500 companies.